I agree HDC. There has been a delay in the trial and the ceo announced it, with a brief explanation, and the statement they expect to be going to the FDA with robust results. The US broker expanded the explanation a little and confirmed his $6 price target, yet the market is treating it like the trial failed. Short traders in the US are having a ball and the strangest thing of all is that the ASX price is leading the price down supposedly with no shorts.
Can anybody confirm that it is not permitted to short Pran, and is it common practice for the brokers to do it anyway?
From my point of view nothing has changed in the odds for the IMAGINE trial. If you believe Mr Kempler the odds of the Reach2HD trial just got better, but I have seen CEOs fooled by placebo effect before, so until results I have to say the odds for Reach2HD have not changed much, but maybe a little better.
As I stated before having the results emerge closer together may be a much better effect.
It is looking very oversold.
coiled spring?, page-10
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $570 | 149.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 13513113 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 130775819 | 29 |
View Market Depth
| Last trade - 15.46pm 27/09/2024 (20 minute delay) ? |
| ATH (ASX) Chart |